Sign in or Register   Sign in or Register
  |  

EXT1

This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq]
Full Name
exostosin 1
Research Area
Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).
Biological Process
Antigen processing and presentation Source: Ensembl
Axon guidance Source: Ensembl
Basement membrane organization Source: Ensembl
Blood vessel remodeling Source: Ensembl
BMP signaling pathway Source: Ensembl
Bone resorption Source: Ensembl
Canonical Wnt signaling pathway Source: Ensembl
Cartilage development involved in endochondral bone morphogenesis Source: Ensembl
Cell adhesion mediated by integrin Source: Ensembl
Cell fate commitment Source: Ensembl
Cellular polysaccharide biosynthetic process Source: BHF-UCL
Cellular response to virus Source: Ensembl
Chondrocyte hypertrophy Source: Ensembl
Chondrocyte proliferation Source: Ensembl
Chondroitin sulfate metabolic process Source: Ensembl
Collagen fibril organization Source: Ensembl
Cranial skeletal system development Source: Ensembl
Dendrite self-avoidance Source: Ensembl
Dendritic cell migration Source: Ensembl
Developmental growth involved in morphogenesis Source: Ensembl
Embryonic skeletal joint development Source: Ensembl
Endochondral bone growth Source: Ensembl
Endochondral ossification Source: Ensembl
Endoderm development Source: Ensembl
Epithelial tube branching involved in lung morphogenesis Source: Ensembl
Fear response Source: Ensembl
Fibroblast growth factor receptor signaling pathway Source: Ensembl
Fluid transport Source: Ensembl
Gastrulation Source: Ensembl
Gene expression Source: Ensembl
Glandular epithelial cell differentiation Source: Ensembl
Glomerular basement membrane development Source: Ensembl
Glomerular visceral epithelial cell differentiation Source: Ensembl
Glycosaminoglycan biosynthetic process Source: BHF-UCL
Hair follicle morphogenesis Source: Ensembl
Heart contraction Source: Ensembl
Heart field specification Source: Ensembl
Hematopoietic stem cell differentiation Source: Ensembl
Hematopoietic stem cell homeostasis Source: Ensembl
Hematopoietic stem cell migration to bone marrow Source: Ensembl
Heparan sulfate proteoglycan biosynthetic process Source: BHF-UCL
Heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process Source: BHF-UCL
Heparin biosynthetic process Source: Ensembl
Hypersensitivity Source: Ensembl
Leukocyte tethering or rolling Source: Ensembl
Limb joint morphogenesis Source: Ensembl
Lymphocyte adhesion to endothelial cell of high endothelial venule Source: Ensembl
Lymphocyte migration into lymphoid organs Source: Ensembl
Mesenchymal cell differentiation involved in bone development Source: Ensembl
Mesoderm development Source: Ensembl
Motor behavior Source: Ensembl
Multicellular organismal water homeostasis Source: Ensembl
Multicellular organism growth Source: Ensembl
Neural crest cell differentiation Source: Ensembl
Olfactory bulb development Source: Ensembl
Optic nerve development Source: Ensembl
Ossification Source: BHF-UCL
Ossification involved in bone maturation Source: Ensembl
Perichondral bone morphogenesis Source: Ensembl
Protein catabolic process Source: Ensembl
Protein-containing complex assembly Source: Ensembl
Protein glycosylation Source: UniProtKB-UniPathway
Regulation of blood pressure Source: Ensembl
Response to heparin Source: Ensembl
Response to leukemia inhibitory factor Source: Ensembl
Response to light intensity Source: Ensembl
Sebaceous gland development Source: Ensembl
Signal transduction Source: ProtInc
Skeletal system development Source: ProtInc
Smoothened signaling pathway involved in lung development Source: Ensembl
Social behavior Source: Ensembl
Sodium ion homeostasis Source: Ensembl
Stem cell division Source: Ensembl
Stomach development Source: Ensembl
Sulfation Source: Ensembl
Sweat gland development Source: Ensembl
Synaptic transmission, glutamatergic Source: Ensembl
Tight junction organization Source: Ensembl
TNFSF11-mediated signaling pathway Source: Ensembl
Vacuole organization Source: Ensembl
Vasodilation Source: Ensembl
Vocalization behavior Source: Ensembl
Wound healing Source: Ensembl
Cellular Location
Golgi apparatus membrane; Endoplasmic reticulum membrane. The EXT1/EXT2 complex is localized in the Golgi apparatus.
Involvement in disease
Hereditary multiple exostoses 1 (EXT1):
EXT is a genetically heterogeneous bone disorder caused by genes segregating on human chromosomes 8, 11, and 19 and designated EXT1, EXT2 and EXT3 respectively. EXT is a dominantly inherited skeletal disorder primarily affecting endochondral bone during growth. The disease is characterized by formation of numerous cartilage-capped, benign bone tumors (osteocartilaginous exostoses or osteochondromas) that are often accompanied by skeletal deformities and short stature. In a small percentage of cases exostoses have exhibited malignant transformation resulting in an osteosarcoma or chondrosarcoma. Osteochondromas development can also occur as a sporadic event.
Tricho-rhino-phalangeal syndrome 2 (TRPS2):
The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration resulting in the loss of functional copies of TRPS1 and EXT1 has been found in TRPS2 patients. A syndrome that combines the clinical features of tricho-rhino-phalangeal syndrome type 1 and multiple exostoses type 1. Affected individuals manifest multiple dysmorphic facial features including large, laterally protruding ears, a bulbous nose, an elongated upper lip, as well as sparse scalp hair, winged scapulae, multiple cartilaginous exostoses, redundant skin, and mental retardation.
Chondrosarcoma (CHDSA):
A malignant neoplasm derived from cartilage cells. Chondrosarcomas range from slow-growing non-metastasizing lesions to highly aggressive metastasizing sarcomas.
Topology
Cytoplasmic: 1-7
Helical: 8-28
Lumenal: 29-746

Anti-EXT1 antibodies

Loading...
Target: EXT1
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: 5A5
Application*: WB, E
Target: EXT1
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: CBFYE-1413
Application*: SE, E, WB
Target: EXT1
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: CBFYE-1414
Application*: E, WB
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)
Go to
Compare